CMPX compared with UPB: revenue, margins and what each company keeps, and the suppliers and customers both name

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

UPBUpstream Bio, Inc.

Mkt capRevenueRevenue

Compare

CMPXCompass Therapeutics, Inc.

UPBUpstream Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CMPX: latest quarter is a loss; flow not drawable. UPB: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CMPX 5

—ABL Biounlistedsupplier

—Adimabunlistedsupplier

—B. Riley Securitiesunlistedsupplier

—Elpiscience Biopharmaceuticalsunlistedsupplier

1 more · CMPX chain ›

Shared 0

No shared counterparties.

Only UPB 5

REGNRegeneron Pharmaceuticalssupplier

—Astellas Pharmaunlistedsupplier

—Lonza Salesunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Wuxi Biologics (Hong Kong)

unlistedsupplier

1 more · UPB chain ›

Price

rebased to 0%

CMPX, solidUPB, dashed

CMPXCompass Therapeutics, Inc.

0.79▲+3.85%· post 0.79

Mkt cap$141.6MRevenue$850,000Q2 FY24Revenue—

UPBUpstream Bio, Inc.

3.41▲+4.28%· post 3.40

ClosedOct 30 '26

Mkt cap$186.1MRevenue$773,000Q2 FY26Revenue$3MFY25

Compare

ClosedOct 30 '26

CMPXCompass Therapeutics, Inc.

UPBUpstream Bio, Inc.

0.79▲+3.85%post 0.79

Price

3.41▲+4.28%post 3.40

$141.6M

Mkt cap

$186.1M

Q2 FY24$850,000

Revenue

$773,000Q2 FY26

—

Revenue

$3MFY25

CMPX0.79▲+3.85%vsUPB3.41▲+4.28%ClosedOct 30 '26